Fischer Medical Ventures Ltd Closes Trading Window for 31st March 2026

Fischer Medical Ventures Ltd has announced the closure of its trading window for promoters, directors, and designated persons from 1st April 2026 until 48 hours after the declaration of the Audited Financial Results for the year ending March 31, 2026. This decision is in accordance with the Company's code of conduct for Prohibition of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015. The Board Meeting to consider and approve the Audited Financial Results for the year ending March 31, 2026, will be held separately, with the notice sent to the Stock Exchanges. Designated persons and their immediate relatives have been informed not to trade in the Company's securities during this period.